Back
Karyopharm Therapeutics Stock Price Chart
BREAKING: Elon Musk's Secret A.I. Project Set to Plunge Millions of Americans Into Poverty
Click here now to prepare yourself for what's around the corner
Sell
32
KPTI
Karyopharm Therapeutics
Last Price:
1.09
Seasonality Move:
-6.84%
7 Day Trial
ALL ACCESS PASS
$
7
$50 trade to make today with huge potential!
Click here to access my #1 options strategy for overnight wins starting with $50!- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KPTI is experiencing selling pressure, which indicates risk of future bearish movement.
Karyopharm Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.19 | Sell |
| 20-day SMA: | 1.31 | Sell |
| 50-day SMA: | 1.33 | Sell |
| 200-day SMA: | 1.19 | Sell |
| 8-day EMA: | 1.19 | Sell |
| 20-day EMA: | 1.26 | Sell |
| 50-day EMA: | 1.27 | Sell |
| 200-day EMA: | 1.49 | Sell |
Karyopharm Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 40.52 | Sell |
| Chaikin Money Flow: | -1207639 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.19 - 1.45) | Sell |
| Bollinger Bands (100): | (0.83 - 1.39) | Sell |
Karyopharm Therapeutics Technical Analysis
| Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Karyopharm Therapeutics Stock
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 1.09 while KPTI 8-day simple moving average is 1.19, which is a Sell signal.
- The stock price of KPTI is 1.09 while Karyopharm Therapeutics 20-day SMA is 1.31, which makes it a Sell.
- Karyopharm Therapeutics 50-day simple moving average is 1.33 while KPTI share price is 1.09, making it a Sell technically.
- KPTI stock price is 1.09 and Karyopharm Therapeutics 200-day simple moving average is 1.19, creating a Sell signal.
KPTI Technical Analysis vs Fundamental Analysis
Sell
32
Karyopharm Therapeutics (KPTI)
is a Sell
Is Karyopharm Therapeutics a Buy or a Sell?
-
Karyopharm Therapeutics stock is rated a Sell
The current Karyopharm Therapeutics [KPTI] share price is $1.09. The Score for KPTI is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Karyopharm Therapeutics Stock Info
Market Cap:
125.42M
Price in USD:
1.09
Share Volume:
1.55M
Karyopharm Therapeutics 52-Week Range
52-Week High:
4.09
52-Week Low:
0.62
Sell
32
Karyopharm Therapeutics (KPTI)
is a Sell
Karyopharm Therapeutics Share Price Forecast
-
What is the Karyopharm Therapeutics stock price today?
The Karyopharm Therapeutics stock price is 1.09 USD today. -
Will KPTI stock go up or go down?
Karyopharm Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Karyopharm Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Karyopharm Therapeutics is overvalued.
Is Karyopharm Therapeutics Stock a Buy?
- Karyopharm Therapeutics share price is 1.09 while KPTI 8-day exponential moving average is 1.19, which is a Sell signal.
- The stock price of KPTI is 1.09 while Karyopharm Therapeutics 20-day EMA is 1.26, which makes it a Sell.
- Karyopharm Therapeutics 50-day exponential moving average is 1.27 while KPTI share price is 1.09, making it a Sell technically.
- KPTI stock price is 1.09 and Karyopharm Therapeutics 200-day simple moving average is 1.49, creating a Sell signal.
Fundamental Analysis of Karyopharm Therapeutics
Is Karyopharm Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.02 per share, and an increase next year of $0.20 per share.
Technical Analysis of Karyopharm Therapeutics
Should I short Karyopharm Therapeutics stock?
- KPTI Moving Average Covergence Divergence (MACD) indicator is -0.06, suggesting Karyopharm Therapeutics is a Sell
- Karyopharm Therapeutics Relative Strength Index (RSI) is 40.52, which suggest Karyopharm Therapeutics is oversold
- The Bollinger Bands (25) for Karyopharm Therapeutics is (1.19 - 1.45), which suggest Karyopharm Therapeutics is a Sell
- The Bollinger Bands (100) for Karyopharm Therapeutics is (0.83 - 1.39), which suggest Karyopharm Therapeutics is a Sell
* Karyopharm Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.